The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22

References

• Kurosaka S, Satoh T, Chow E et al. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy. Ann. Nucl. Med. 26(6), 485–491 (2012).
   PubMedGoogle Scholar
• Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 12(20 Pt 2), 6243s–6249s (2006).
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2(8), 584–593 (2002).
   PubMed Web of Science ®Google Scholar
• Chow E, Nguyen J, Zhang L et al. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 118(5), 1457–1465 (2012).
   PubMedGoogle Scholar
• Jensen AO, Jacobsen JB, Norgaard M, Yong M, Fryzek JP, Sorensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer 11, 29 (2011).
   PubMed Web of Science ®Google Scholar
• Wardley A, Davidson N, Barrett-Lee P et al. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. Br. J. Cancer 92(10), 1869–1876 (2005).
   PubMedGoogle Scholar
• Chow E, Hird A, Velikova G et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur. J. Cancer 45(7), 1146–1152 (2009).
   PubMedGoogle Scholar
• Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone (12 Suppl. 1), S9–S10 (1991).
   Google Scholar
• Tharmalingam S, Chow E, Harris K, Hird A, Sinclair E. Quality of life measurement in bone metastases: a literature review. J. Pain Res. 1, 49–58 (2008).
   PubMedGoogle Scholar
• Soni MK, Cella D. Quality of life and symptom measures in oncology: an overview. Am. J. Manag. Care 8(18 Suppl.) S560–S573 (2002).
   PubMed Web of Science ®Google Scholar
• Santoro M, Cicero G, Condemi G et al. Pain Management and quality life in bone metastasis from breast cancer: role of radiotherapy. Cancer Treat. Rev. 36, S104–S104 (2010).
   Google Scholar
• Costa L, Major PP. Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nature Clinical Practice Oncology, 6(3), 163–174 (2009).
   PubMedGoogle Scholar
• Harris K, Chow E, Zhang L et al. Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases. Eur. J. Cancer 45(14), 2510–2518 (2009).
   PubMedGoogle Scholar
• Rustoen T, Moum T, Padilla G, Paul S, Miaskowski C. Predictors of quality of life in oncology outpatients with pain from bone metastasis. J. Pain Symptom Manage. 30(3), 234–242 (2005).
   PubMed Web of Science ®Google Scholar
• Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases. Expert Rev. Pharmacoecon. Outcomes Res. 12(2), 213–219 (2012).
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85(5), 365–376 (1993).
   PubMed Web of Science ®Google Scholar
• Montazeri A, Harirchi I, Vahdani M et al. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version. Support Care Cancer 7(6), 400–406 (1999).
   PubMed Web of Science ®Google Scholar
• Fayers PM, Aaronson NK, Bjordal K et al. The EORTC QLQ-C30 scoring manual (3rd Edition). European Organisation for Research and Treatment of Cancer, Brussels, Belgium (2001).
   Google Scholar
• Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother. Oncol. 64(3), 275–280 (2002).
   PubMed Web of Science ®Google Scholar
• Cull A, Sprangers MAG, Aaronson NK. Internal report of the EORTC Study Group on Quality of Life: European Organization for Research and Treatment of Cancer quality of life study group translation procedure (1994).
   Google Scholar
• Khoshnevisan A, Yekaninejad MS, Ardakani SK, Pakpour AH, Mardani A, Aaronson NK. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran. Health Qual. Life Outcomes, 10, 54.
   PubMedGoogle Scholar
• Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual. Life Res. 2(6), 441–449 (1993).
   PubMed Web of Science ®Google Scholar
• Nunnally JC, Bernstein IR. Psychometric Theory (3rd Edition). McGraw-Hil, NY, USA (1994).
   Google Scholar
• Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol. Rep. 19, 3–11 (1966).
   PubMed Web of Science ®Google Scholar
• Bagozzi RP, Yi Y, Phillips LW. Assessing construct validity in organizational research. Adm. Sci. Q. 36, 421–458. (1991).
   Web of Science ®Google Scholar
• Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation John Wiley & Sons, Chichester, UK (2000).
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Statistical Society: Series B 57, 289–300 (1995).
   Web of Science ®Google Scholar
• Cohen J. A power primer. Psychol. Bull 112, 155–159 (1992).
   PubMed Web of Science ®Google Scholar
• Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociological Methods Res. 21, 230–258 (1992).
   Web of Science ®Google Scholar
• Jöreskog KG, Sörbom D. LISREL 8.80 for Windows [Computer Software]. Scientific Software International Inc., Lincolnwood, IL, USA (2006).
   Google Scholar
• Mahjoubi B, Mirzaei R, Azizi R, Jafarinia M, Zahedi-Shoolami L. A cross-sectional survey of quality of life in colostomates: a report from Iran. Health Qual. Life Outcomes 10, 136 (2012).
   PubMedGoogle Scholar
• Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur. J. Cancer 34, 1381–1389 (1998).
   PubMed Web of Science ®Google Scholar
• French B, Finch W. Confirmatory factor analytic procedures for the determination of measurement invariance. Struct. Equation Model. 13, 378–402 (2006).
   Web of Science ®Google Scholar
• Cheung GW, Rensvold RB. Evaluating goodness-of-fit indexes for testing measurement invariance. Struct. Equation Model. 9, 233–255 (2002).
   Web of Science ®Google Scholar
• Horn JL, McArdle JJ. A practical and theoretical guide to measurement invariance in aging research. Exp. Aging Res. 18, 117–144 (1992).
   PubMed Web of Science ®Google Scholar
• Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med. Care 28(7), 632–642 (1990).
   PubMed Web of Science ®Google Scholar
• Chow E, Nguyen J, Zhang LY et al. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 118(5), 1457–1465 (2012).
   PubMedGoogle Scholar
• Pud D. Gender differences in predicting quality of life in cancer patients with pain. Eur. J. Oncol. Nurs. 15(5), 486–491 (2011).
   PubMed Web of Science ®Google Scholar
• Miaskowski C. Gender differences in pain, fatigue, and depression in patients with cancer. J. Natl Cancer Inst. Monogr. (32), 139–143 (2004).
   PubMedGoogle Scholar
• Fouladbakhsh JM, Stommel M. Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol. Nurs. Forum, 37(1), E7–E15 (2010).
   PubMedGoogle Scholar
• Harris K, Chow E, Zhang L et al. Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases. Eur. J. Cancer 45, 2510–2518 (2009).
   PubMed Web of Science ®Google Scholar
• Bernhard J, Ganz PA. Psychosocial issues in lung cancer patients (Part 1). Chest 99(1), 216–223 (1991).
   PubMed Web of Science ®Google Scholar